Evidence map›Paper›PMID 41853238›Full record

ArticleADMET & DMPK2026

Imipramine solubility-pH profiles: self-aggregation

Olivera S Marković, Miloš P Pešić, Alex Avdeef, Abu T M Serajuddin, Tatjana Ž Verbić

Abstract read
In one paragraph

Article in ADMET & DMPK, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Olivera S MarkovićUniversity of Belgrade - Institute of Chemistry, Technology and Metallurgy - National Institute of the Republic of Serbia, Department of Chemistry, Njegoševa 12, 11000 Belgrade, Republic of Serbia.ORCID 0000-0001-5830-1445
Miloš P PešićUniversity of Belgrade - Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Republic of Serbia.ORCID 0000-0002-1982-040X
Alex Avdeefin-ADME Research, New York, NY 10128, USA.ORCID 0000-0002-3139-5442
Abu T M SerajuddinSt. John's University, College of Pharmacy and Health Sciences, 8000 Utopia Parkway, Queens, NY 11439, USA.ORCID 0000-0002-2596-715X
Tatjana Ž VerbićUniversity of Belgrade - Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Republic of Serbia.ORCID 0000-0002-6348-1644

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: The pH-dependent solubility of imipramine, a tricyclic antidepressant, and its hydrochloride salt was investigated in phosphate buffers and chloride-containing aqueous media using the pH-ramp shake-flask method. It was reported that aggregation of imipramine in acidic media and its partial degradation in alkaline media complicate the determination of its solubility. This was further investigated with modified methods. Experimental approach: For imipramine solubility studies, the computer program Key results: A detailed analysis of imipramine pH-solubility profiles reveals complex equilibria in the aqueous phase, as well as various solid-phase transformations. Intrinsic solubility of imipramine, solubility products of imipramine hydrochloride and imipramine phosphate salts, and aggregation constants (trimer, heptamer, and cationic complex with phosphate ions) were determined. Solid state characterization results are in accordance with pDISOL-X analysis. Conclusion: These findings, along with our previous solubility studies of desipramine and nortriptyline, suggest that even subtle structural variations can lead to significant differences in the aqueous media behaviour of tricyclic antidepressants. This type of information can be valuable in the early stages of drug discovery, in formulation optimization experiments, as well as in

Indexed as

chloride saltcritical micellar concentrationpH and buffer effectphosphate saltpH-ramp shake-flask methodsolubility product

Identifiers

PMID41853238
PMCPMC12994603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.